Incyte Corp. (INCY)
123.40
-0.97
(-0.78%)
USD |
NASDAQ |
Aug 31, 11:49
Incyte Cash from Operations (Annual) : 1.413B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 1.413B |
| December 31, 2024 | 335.34M |
| December 31, 2023 | 496.49M |
| December 31, 2022 | 969.94M |
| December 31, 2021 | 749.49M |
| December 31, 2020 | -124.60M |
| December 31, 2019 | 710.66M |
| December 31, 2018 | 336.23M |
| December 31, 2017 | -92.99M |
| December 31, 2016 | 304.76M |
| December 31, 2015 | 86.54M |
| December 31, 2014 | 25.99M |
| December 31, 2013 | 9.18M |
| December 31, 2012 | -94.83M |
| December 31, 2011 | -161.72M |
| December 31, 2010 | 97.94M |
| December 31, 2009 | 12.36M |
| Date | Value |
|---|---|
| December 31, 2008 | -140.86M |
| December 31, 2007 | -92.69M |
| December 31, 2006 | -50.37M |
| December 31, 2005 | -101.87M |
| December 31, 2004 | -114.67M |
| December 31, 2003 | -118.33M |
| December 31, 2002 | -58.27M |
| December 31, 2001 | -47.00M |
| December 31, 2000 | -7.344M |
| December 31, 1999 | -21.45M |
| December 31, 1998 | 36.23M |
| December 31, 1997 | 18.72M |
| December 31, 1996 | 16.00M |
| December 31, 1995 | -8.967M |
| December 31, 1994 | -6.274M |
| December 31, 1993 | -4.426M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Mirum Pharmaceuticals, Inc. | 55.83M |
| Regeneron Pharmaceuticals, Inc. | 4.979B |
| Eli Lilly & Co. | 16.81B |
| AbbVie, Inc. | 19.03B |
| Biogen, Inc. | 2.205B |